WednesdayNov 05, 2025 10:00 am

Cancer Immunotherapy Could Be Transformed by Boosting Natural Killer Cells

Researchers at MIT and Harvard Medical School have developed a method to enhance natural killer cells that could transform cancer immunotherapy. The team engineered chimeric antigen receptor natural killer cells with modifications that prevent immune system rejection and improve their ability to destroy tumors. Early experiments in mice and laboratory human tissue show the enhanced cells are effective at fighting cancer and well tolerated, offering a promising foundation for next-generation treatments.  Natural killer cells function as the body's first defense against virus-infected or cancerous tissue. They react immediately to suspect cells without requiring activation or priming. Chimeric antigen receptors engineered…

Continue Reading

MondayNov 03, 2025 10:00 am

China Moves to End Subsidies to its EV Industry

Beijing has removed electric vehicles from its list of strategic emerging industries for the first time in over a decade, signaling a fundamental shift in how the world's largest automotive market will support its dominant EV sector. The exclusion of NEVs from China's 2026-2030 five-year development plan indicates policymakers believe the industry has matured enough to compete without tens of billions’ worth of government subsidies and customer incentives.  Market forces rather than policy directives will now determine which manufacturers survive China's increasingly competitive EV market. Data from Jato Dynamics research shows that 93 of the 169 automakers currently operating in…

Continue Reading

WednesdayOct 29, 2025 9:00 am

AMD Shares Jump as IBM Says its Existing Chips Can Correct Quantum Computing Errors

AMD shares surged by nearly 8% on Friday after IBM announced that standard AMD chips can run a critical quantum computing error correction algorithm. Investors' response to the breakthrough in qubit technology advancement caused IBM stock to climb approximately 8% as well, heading toward its best single-day performance since January. A recent report revealed that IBM can successfully operate error correction algorithms in real time on AMD's field programmable gate array chips, marking significant progress toward building commercially viable quantum computers. The development addresses one of quantum computing's most persistent challenges: managing the errors that plague qubit-based systems that can…

Continue Reading

MondayOct 27, 2025 10:00 am

Scientists Uncover Possible Driver of ‘Chemo Brain’

A recent study has found that the cognitive difficulties which cancer patients experience during and after treatment could stem from chemotherapy-induced damage to the brain's waste drainage network. Newly discovered evidence sheds light on a widespread yet poorly understood phenomenon that affects up to 75% of individuals undergoing cancer therapy, chemo brain. The symptoms associated with this condition, including memory lapses and problems with concentration and finding words, typically persist long after treatment is complete.  Published in the journal Communications Biology, the study examined how common cancer drugs impact meningeal lymphatics, specialized vessels within the brain membranes responsible for waste…

Continue Reading

WednesdayOct 22, 2025 10:00 am

Study Suggests mRNA Covid Vaccine Could Boost Cancer Immunotherapy

New research published at the European Society for Medical Oncology conference on Sunday has revealed that the mRNA coronavirus vaccine could have an unintended benefit: boosting immunotherapy effectiveness.  Although the research is still in its initial phases, experts say Covid vaccines may be able to improve immune function during immunotherapy and make the treatment more potent. Immunotherapy is a relatively new cancer treatment that uses a patient's immune system to fight tumor cells, avoiding the side effects typically associated with chemotherapy and radiation.  The connection between coronavirus vaccines and improved immunotherapy efficacy will be explored further in a Phase 3…

Continue Reading

MondayOct 20, 2025 10:00 am

Chinese EV Exports Doubled YoY in September, Data Shows

Chinese automakers shipped 222,000 electric and plug-in hybrid vehicles internationally through September, marking a 100% surge compared to the prior year. The China Association of Automobile Manufacturers reported the figures alongside domestic passenger car sales that climbed 11.2% over the same period.  These numbers reveal resilient demand despite intense competitive pressures that are fragmenting the world's largest automotive market. The export acceleration shows how manufacturers are increasingly depending on foreign sales to compensate for deteriorating margins at home.  Domestic price wars have created substantial pressure for Chinese automakers and pushed them to aggressively pursue growth opportunities overseas. Recent investment allocation…

Continue Reading

MondayOct 13, 2025 10:00 am

New AI Tool Boosts Precision Medicine in Treating CNS Cancers 

Harvard Medical School researchers have developed an AI system that distinguishes glioblastoma from other brain tumors during surgery. The tool called PICTURE achieved 99.8% accuracy in differentiating glioblastoma from primary central nervous system lymphoma. This rare malignancy is frequently misdiagnosed as glioblastoma, yet the AI system outperformed nine human neuropathologists who misclassified lymphoma as glioblastoma in 38% of test cases.  With over 100 distinct subtypes, central nervous system tumors involve exceptional diagnostic complexity. Glioblastoma represents the most common variety, with patients typically receiving surgical tumor removal but facing a median survival of just eight months. Primary CNS lymphoma shares overlapping…

Continue Reading

MondayOct 13, 2025 9:45 am

PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Reports FY 2025 Increase in Independent Power Producer (‘IPP’) Revenues and Assets from IPP Portfolio Expansion

This article has been disseminated on behalf of PowerBank and may include paid advertising. The company reported a 1,508% increase in revenues from its IPP segment in FY 2025. Total company assets rose 253% year-over-year, driven by IPP expansion and strategic project acquisitions. Gross margin improved to 25% from 20% in FY 2024. The company announced up to US$100 million in project-based financing through a mandate with CIM Group. PowerBank’s development pipeline now totals 1,806 (MWdc, MWh) of solar PV and battery energy storage projects. CEO Dr. Richard Lu highlighted a transition toward long-term recurring revenue through asset ownership and financing.…

Continue Reading

ThursdayOct 09, 2025 11:15 am

Vision Marine Technologies Inc. (NASDAQ: VMAR) Announces Partnership to Launch Quebec’s First Multilevel Electric Boating Showcase

The initiative reaffirms Vision Marine’s commitment to strengthen its presence in Québec. The partnership with Port de plaisance La Ronde signifies a step forward in VMAR’s mission to revolutionize the boating experience through clean-energy solutions. Vision Marine Technologies is at the forefront of the electric boating industry, specializing in high-performance electric propulsion systems and electric boats. In a groundbreaking move for sustainable boating, Vision Marine Technologies (NASDAQ: VMAR) has announced a strategic partnership with Port de plaisance La Ronde in Montreal, Quebec (https://ibn.fm/ekBvm). This collaboration aims to introduce the region’s first multilevel electric boating showcase, setting the stage for a new era…

Continue Reading

WednesdayOct 08, 2025 10:00 am

Researchers Discover Why Cancer Immunotherapy Could Be Failing 

A new study from Ohio State University Wexner Medical Center has discovered why immunotherapy fails in 60-80% of cancer patients. Researchers identified a previously unknown stress pathway called TexPSR that floods weakened immune cells with misfolded proteins, crippling their ability to attack tumors. Blocking this pathway in laboratory models restored immune cell function and significantly improved immunotherapy effectiveness across multiple cancer types.  Immune system T cells recognize and fight infections and cancer, but often become weakened and lose effectiveness during prolonged battles with tumors. The Ohio State team found these depleted T cells collapse under misfolded proteins that trigger TexPSR,…

Continue Reading

Contact us: (512) 354-7000